Treatment for Myopia

Phase-Based Estimates
1
Effectiveness
1
Safety
EyeQue, Newark, CA
+5 More
Eligibility
18+
All Sexes
Eligible conditions
Myopia

Study Summary

This study is evaluating whether a device which measures your vision can help you select glasses that will improve your vision.

See full description

Eligible Conditions

  • Myopia
  • Hyperopia
  • Astigmatism
  • Vision, Low
  • Micropsia
  • Visual Impairment
  • Vision Disorders

Treatment Effectiveness

Effectiveness Estimate

1 of 3

Study Objectives

This trial is evaluating whether Treatment will improve 1 primary outcome in patients with Myopia. Measurement will happen over the course of Visit 1: Day 0.

Visit 1: Day 0
Visual Acuity with and without try-on glasses

Trial Safety

Safety Estimate

1 of 3

Trial Design

1 Treatment Groups

Control

This trial requires 100 total participants across 1 different treatment groups

This trial involves a single treatment. Treatment is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.

ControlNo treatment in the control group

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: visit 1: day 0
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly visit 1: day 0 for reporting.

Closest Location

EyeQue - Newark, CA

Eligibility Criteria

This trial is for patients born any sex aged 18 and older. There are 7 eligibility criteria to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
The EyeQue refraction device yielded EGNs. show original
We would like to use the VisionCheck refraction and try-on glasses measurements that were taken prior to study participation. show original
I ordered some glasses based on my EyeQue EyeGlass Numbers. show original
Male or Female
Ages 30+
She had purchased an EyeQue refraction device. show original
Subject

Patient Q&A Section

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many people get micropsia a year in the United States?

Add answer

Based off the small sample size, micropsia is a common feature among adults which may be a result of aging, cigarette smoking, anxiety, or other unrecognized comorbidities. Future prospective studies are needed to characterize micropsia’s effects.

Unverified Answer

What are the signs of micropsia?

Add answer

Micropsia can occur without an optical defect. If micropsia is associated with an occult lesion, the diagnosis of micropsia is made without undue concern for its etiology.

Unverified Answer

What are common treatments for micropsia?

Add answer

There exists no single treatment or set of treatments to reverse the perception of magnification in micropsia. Patients are often instructed to use visual cues, such as close-up of the objects or switching positions, to help them compensate.

Unverified Answer

Can micropsia be cured?

Add answer

A number of treatments with some success had been tried that included a variety of approaches including: (1) a change in the visual environment (vision therapy) of looking at the globe, which has proven to be effective in the treatment of micropsia; (2) surgery for treatment of the brainstem; (3) treatment of the visual cortex by excitatory (electro stimulation) or inhibitory (chemical therapy) stimulation by a variety of medications, and (4) stereotactic surgery. The surgical approaches of micropsia include: [electrophysiologically guided neurosurgery, (EAPNS) in a manner that was developed by Dr.

Unverified Answer

What is micropsia?

Add answer

Micropsia describes vision of the optic disc and/or peripheral field defects. It is common to see the optic disc as being larger than the central fovea in patients with micropsia. Micropsia can vary from mild astigmatism to a full-blown macropsia. In both cases, micropsia is not a disease. It is a symptom of certain pathological conditions. Clinicians and scientists should be aware that micropsia has little do to do with disease but rather, it is the result of a combination of factors. These factors include retinal thickness, a high amount of retinal neural cell, and changes in the thickness of the retina, especially among those persons who suffer from cataract.

Unverified Answer

What causes micropsia?

Add answer

Micropsia can be caused due to a change in the refractive power of the retina, or in some people, a change in the axial length of the eye. This is in contrast with diplopia, which occurs because of changes in the shape of the visual field.

Unverified Answer

What is the average age someone gets micropsia?

Add answer

The majority of patients reported micropsia as non-symptomatic and in the benign range. As expected the number of patients with micropsia increases with age and with increasing BMI. The number of patients who suffer some form of vision disturbance should be taken into account when considering the diagnostic value of micropsia.

Unverified Answer

What are the latest developments in treatment for therapeutic use?

Add answer

The latest developments in treatment for pathological use are now a big reality. The need for a fast recovery after surgical therapy is not a problem anymore.

Unverified Answer

Who should consider clinical trials for micropsia?

Add answer

[Not all eye diseases can be treated in clinical trials. Clinical trials can help guide the selection of treatments for specific ocular diseases.] When looking for treatment for micropsia, [Power] allows clinicians to find clinical trials that are the best for you and your family [in the short run]. However, patients and their families that want to receive treatment in the long run should make their decisions based on a careful review of all of the available clinical trials.

Unverified Answer

Does treatment improve quality of life for those with micropsia?

Add answer

[The use of micropsia has improved physical function in a population of patients with micropsia, which suggests an improvement in the quality of life of this patient group. Further prospective collaborative work is needed to delineate the contribution of micropsia to the burden of disease, and to evaluate the role of micropsia in symptom dimensions and as a predictor of health service use and service use by patients with micropsia.

Unverified Answer

Is treatment safe for people?

Add answer

Results from a recent paper of the trial show that in patients with [multiple myeloma](https://www.withpower.com/clinical-trials/multiple-myeloma) who are undergoing interferon therapy, treatment does not increase the risk of myeloma progression, despite a trend to shorter survival compared with placebo.

Unverified Answer

What is treatment?

Add answer

This case demonstrates that a multidisciplinary approach to complicated cases of micropsia can be effective. While the initial use of visual correction strategies were successful in managing symptoms, they were ineffective in achieving complete resolution of micropsia. A multidisciplinary approach including surgeons, optometrists, oculo-optometric technicians, neuro-optometric technicians, nurses, and nutritionists was successful in achieving sustained symptom control.

Unverified Answer
See if you qualify for this trial
Get access to this novel treatment for Myopia by sharing your contact details with the study coordinator.